...
首页> 外文期刊>Neurosurgical focus >Ten years’ experience with intraoperative MRI-assisted transsphenoidal pituitary surgery
【24h】

Ten years’ experience with intraoperative MRI-assisted transsphenoidal pituitary surgery

机译:十年的术中MRI辅助胸腔垂体手术经验

获取原文
           

摘要

OBJECTIVE Many innovations have been introduced into pituitary surgery in the quest to maximize the extent of tumor resection. Because of the deep and narrow surgical corridor as well as the heterogeneity of confronted pathologies, anatomical orientation and identification of the target tissue can become difficult. Intraoperative MRI (iMRI) may have the potential to increase extent of resection (EOR) in transsphenoidal pituitary surgery. Furthermore, it may simplify anatomical orientation and risk assessment in difficult cases. Here, the authors evaluated the additional value of iMRI for the resection of pituitary adenomas performed in the past 10 years in their department. METHODS They performed a retrospective single-center analysis of patients treated for pituitary adenoma in their department after the introduction of iMRI between 2008 and 2018. Of 495 transsphenoidal approaches, 300 consecutive MRI-assisted surgeries for pituitary adenomas encompassing 294 patients were selected for further analysis. Microscopic, endoscopic, or endoscope-assisted microscopic transsphenoidal approaches were distinguished. EOR as well as additional resection following iMRI was evaluated via detailed volumetric analysis. Patients were stratified according to the Knosp adenoma classification. Furthermore, demographic data, clinical symptoms, endocrine outcome, and complications were evaluated. Univariable and multivariable Cox regression analyses of progression-free survival (PFS) were performed. RESULTS Pituitary adenomas classified as Knosp grades 0–2 were found in 60.3% of cases (n = 181). The most common tumors were nonfunctioning adenomas (75%). Continued resection following iMRI significantly increased EOR (7.5%, p 0.001) and the proportion of gross-total resections (GTRs) in transsphenoidal pituitary surgery (54% vs 68.3%, p 0.001). Additional resection after iMRI was performed in 37% of cases. Only in the subgroup of patients with Knosp grades 0–2 adenomas treated with the microsurgical technique was additional resection significantly more common than in the endoscopic group (p = 0.039). Residual tumor volume, Knosp grade, and age were confirmed as independent predictors of PFS (p 0.001, p = 0.021, and p = 0.029, respectively) in a multivariable Cox regression analysis. Improvement of visual field deficits was documented in 78.6% of patients whose optic apparatus had been affected preoperatively. Revision surgery was done in 7.3% of cases; in 5.6% of cases, it was performed for cerebrospinal fluid fistula. CONCLUSIONS In this series, iMRI led to the detection of a resectable tumor remnant in a high proportion of patients, resulting in a greater EOR and higher proportion of GTRs after continued resection in microsurgical and endoscopic transsphenoidal resection of pituitary adenomas. The volume of residual tumor was the most important predictor of PFS. Given the study data, the authors postulated that every bit of removed tumor serves the patient and increases their chances of a favorable outcome.
机译:目的在寻求最大化肿瘤切除程度的垂直手术中,许多创新被引入了垂体手术。由于狭窄的手术走廊以及面对病理的异质性,难以变得困难的解剖学取向​​和靶组织的鉴定。术中MRI(IMRI)可能有可能增加转胸垂体手术中的切除程度(EOR)。此外,它可以在困难的情况下简化解剖学方向和风险评估。在这里,作者评估了IMRI在过去10年中进行的垂体腺瘤切除的额外价值。方法对2008年至2018年间IMRI引入IMRI后,对其部门治疗的患者进行了回顾性单中心分析。在2008年至2018年之间,在495年间接种中,300种随着294名患者的垂体腺瘤的300种连续的MRI辅助手术,进行进一步分析。区分显微镜,内窥镜或内窥镜辅助微观转晶方法。通过详细的体积分析评估IMRI之后的EOR以及额外的切除。患者根据Knosp腺瘤分类分层。此外,评估人口统计数据,临床症状,内分泌结果和并发症。进行无变型和多变量的COX回归分析进行无进展生存(PFS)。结果在60.3%的病例中发现了脑垂体腺瘤,归类为KNOSP等级0-2(n = 181)。最常见的肿瘤是无脆的腺瘤(75%)。 IMRI持续切除显着增加EOR(7.5%,P <0.001)和经胸腔垂体手术总粗术(GTRS)的比例(54%Vs 68.3%,P <0.001)。 IMRI后的额外切除在37%的病例中进行。只有在Knosp等级的患者的亚组中,用显微外科治疗的腺瘤患者进行了额外的切除率明显比内窥镜组更常见(P = 0.039)。在多变量的COX回归分析中,确认残留的肿瘤体积,knosp等级和年龄作为PFS的独立预测因子(P <0.001,P = 0.021和P = 0.029)。在术前影响的78.6%的患者中记录了视野赤字的改进。修订手术是在7.3%的情况下进行的;在5.6%的病例中,它是针对脑脊液瘘进行的。结论在本系列中,IMRI在高比例的患者中导致了检测可重置的肿瘤残余物,导致在垂体和内窥镜胸腔切除垂体腺瘤的显微外科和内窥镜晶状体切除术后的GTR后的更大的EOR和更高比例的GTR。残留肿瘤的体积是PFS最重要的预测因子。鉴于研究数据,作者假设所有取出的肿瘤都为患者提供了患者并增加了他们有利的结果的机会。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号